Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 2
1991 3
1992 1
1993 1
1996 1
2002 3
2003 2
2004 2
2006 1
2007 1
2008 2
2009 3
2010 5
2012 5
2013 2
2014 6
2015 7
2016 3
2017 2
2018 2
2019 3
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors.
Sanchez-Martinez D, Allende-Vega N, Orecchioni S, Talarico G, Cornillon A, Vo DN, Rene C, Lu ZY, Krzywinska E, Anel A, Galvez EM, Pardo J, Robert B, Martineau P, Hicheri Y, Bertolini F, Cartron G, Villalba M. Sanchez-Martinez D, et al. Among authors: villalba m. Theranostics. 2018 Jun 14;8(14):3856-3869. doi: 10.7150/thno.25149. eCollection 2018. Theranostics. 2018. PMID: 30083264 Free PMC article.
Polyoxidonium® Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer.
Alexia C, Cren M, Louis-Plence P, Vo DN, El Ahmadi Y, Dufourcq-Lopez E, Lu ZY, Hernandez J, Shamilov F, Chernysheva O, Vasilieva M, Vorotnikov I, Vishnevskay Y, Tupitsyn N, Rossi JF, Villalba M. Alexia C, et al. Among authors: villalba m. Front Immunol. 2019 Nov 28;10:2693. doi: 10.3389/fimmu.2019.02693. eCollection 2019. Front Immunol. 2019. PMID: 31849934 Free PMC article. Clinical Trial.
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.
Calvo T, Reina-Ortiz C, Giraldos D, Gascón M, Woods D, Asenjo J, Marco-Brualla J, Azaceta G, Izquierdo I, Palomera L, Sánchez-Martínez D, Marzo I, Naval J, Vilches C, Villalba M, Anel A. Calvo T, et al. Among authors: villalba m. Sci Rep. 2020 Nov 10;10(1):19398. doi: 10.1038/s41598-020-76051-z. Sci Rep. 2020. PMID: 33173077 Free PMC article.
Mitochondrial Complex I activity signals antioxidant response through ERK5.
Khan AUH, Allende-Vega N, Gitenay D, Garaude J, Vo DN, Belkhala S, Gerbal-Chaloin S, Gondeau C, Daujat-Chavanieu M, Delettre C, Orecchioni S, Talarico G, Bertolini F, Anel A, Cuezva JM, Enriquez JA, Cartron G, Lecellier CH, Hernandez J, Villalba M. Khan AUH, et al. Among authors: villalba m. Sci Rep. 2018 May 9;8(1):7420. doi: 10.1038/s41598-018-23884-4. Sci Rep. 2018. PMID: 29743487 Free PMC article.
Mutations in the ND2 Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells.
Marco-Brualla J, Al-Wasaby S, Soler R, Romanos E, Conde B, Justo-Méndez R, Enríquez JA, Fernández-Silva P, Martínez-Lostao L, Villalba M, Moreno-Loshuertos R, Anel A. Marco-Brualla J, et al. Among authors: villalba m. Cancers (Basel). 2019 Jul 21;11(7):1027. doi: 10.3390/cancers11071027. Cancers (Basel). 2019. PMID: 31330915 Free PMC article.
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.
Reina-Ortiz C, Constantinides M, Fayd-Herbe-de-Maudave A, Présumey J, Hernandez J, Cartron G, Giraldos D, Díez R, Izquierdo I, Azaceta G, Palomera L, Marzo I, Naval J, Anel A, Villalba M. Reina-Ortiz C, et al. Among authors: villalba m. Oncoimmunology. 2020 Dec 29;10(1):1853314. doi: 10.1080/2162402X.2020.1853314. Oncoimmunology. 2020. PMID: 33457074 Free PMC article.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page